Connecticut

Subscribe to Connecticut via RSS
Photo of Bexis

Add Connecticut to the list of Zantac multi-plaintiff losses, following the Florida multidistrict litigation (our “Zantac Chronicles” series of posts, and the Delaware Supreme Court).  Only this time the several hundred Connecticut plaintiffs that were dismissed never even reached the absurd causation allegations that doomed the MDL and Delaware cases.  Rather, these Connecticut plaintiffs didn’t even have a means to establish personal jurisdiction over the non-Connecticut defendants they sued.  Bacher v. Boehringer Ingelheim Pharmaceuticals, Inc., 2025 WL 2463143 (Conn. Super. Aug. 22, 2025).Continue Reading Hundreds of Non-Resident Zantac Plaintiffs Run Out of Connecticut

Photo of Michelle Yeary

Plaintiffs naming local sales representatives—or doctors, or pharmacies, or distributors, or retailers—as defendants to try to destroy diversity and avoid federal court is nothing new.  Unfortunately, defendants bear a “heavy burden” proving fraudulently joinder.  In fact, our last post on the topic was in February 2023, demonstrating that successes on this issue are few…

Photo of Stephen McConnell

Whoever said “you get what you pay for” never deposed a plaintiff expert.  Most plaintiff experts we’ve encountered acquired their expertise – if that’s what you want to call it – not in any substantive area but, rather, in slinging junk science hash at juries with a straight, and maybe even solemn, face.  As if…

Photo of Eric Alexander

Without detouring into a larger discussion on the impacts of humans on the environment and our fellow animals, we can say that we are big fans of the other extant great apes.  Our puppy’s fascination with nature documentaries has helped pique that interest of late.  Our gingery cousin the orangutan, the largest primarily arboreal mammal…

Drug & Device Resources

Bexis’ Book

FDA-regulated products now account for an estimated one-fifth of overall economic activity in the U.S. They have also been the focus of a litigation explosion. This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.
Learn more about this book